Literature DB >> 29352605

A New Treatment Option for Highly Sensitized Patients Awaiting Kidney Transplantation.

Enver Akalin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29352605     DOI： 10.1053/j.ajkd.2017.10.024

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  3 in total

1.  Progenitor-derived human endothelial cells evade alloimmunity by CRISPR/Cas9-mediated complete ablation of MHC expression.

Authors:  Jonathan Merola; Melanie Reschke; Richard W Pierce; Lingfeng Qin; Susann Spindler; Tania Baltazar; Thomas D Manes; Francesc Lopez-Giraldez; Guangxin Li; Laura G Bracaglia; Catherine Xie; Nancy Kirkiles-Smith; W Mark Saltzman; Gregory T Tietjen; George Tellides; Jordan S Pober
Journal:  JCI Insight       Date:  2019-10-17

2.  Transfusion Status in Liver and Kidney Transplantation Recipients-Results from Nationwide Claims Database.

Authors:  Boyoung Park; Junghyun Yoon; Han Joon Kim; Yun Kyung Jung; Kyeong Geun Lee; Dongho Choi
Journal:  J Clin Med       Date:  2020-11-10       Impact factor: 4.241

3.  BAFF Inhibition Effectively Suppresses the Development of Anti-HLA.A2 Antibody in the Highly Sensitized Mouse Model.

Authors:  Ji Won Min; Yoo-Jin Shin; Hyeyoung Lee; Bo-Mi Kim; Ki Hyun Park; Kyoung Chan Doh; Tae-Min Kim; Sun Woo Lim; Chul Woo Yang; Eun-Jee Oh; Byung Ha Chung
Journal:  Int J Mol Sci       Date:  2021-01-16       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.